Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 184 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: No Conditions Clear all

Conditions: Chest Pain
Interventions: No Fasting prior to catheterization; Other
Lead sponsor: The Guthrie Clinic; Other
Eligibility: 18 Years and older
Enrollment: 619 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Sayre, Pennsylvania

Conditions: Healthy
Interventions: Nilotinib Hydrochloride, calcium carbonate; Drug · Dietary Supplement
Lead sponsor: Jan Beumer; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Healthy
Interventions: Antacids (Mg-Al-based), Imatimib Mesylate (Gleevec®); Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: End Stage Renal Disease
Interventions: VFI using the FAST PV Technology; Device
Lead sponsor: FAST BioMedical; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Burns, Hypertrophic Scar
Interventions: Luminis ultrapulse fractional ablative carbon dioxide laser, 0.5mm punch biopsy; Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sepsis, Respiratory Failure, Renal Failure, Surgical Site Infection
Interventions: Novolin R (human recombinant Insulin); Drug
Lead sponsor: Genesys; Other
Eligibility: 18 Years and older
Enrollment: 317 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Grand Blanc, Michigan

Conditions: Chronic Idiopathic Constipation
Interventions: lubiprostone; Drug
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Obesity, Hypercholesterolemia, Cardiovascular Disease
Interventions: Plant-Based Diet, American Heart Association Diet, Mediterranean Diet; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 9 Years to 18 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: No Conditions, Focus is Respiratory Rate
Interventions: Not listed
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: PTSD
Interventions: TNX-102 SL, Placebo; Drug
Lead sponsor: Tonix Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 245 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 23
States / cities: Tuscaloosa, Alabama • Phoenix, Arizona • Imperial, California + 20 more

Conditions: No Specific Medical Conditions or Disease States
Interventions: Dozee Pro NX; Device
Lead sponsor: Turtle Shell Technologies Pvt. Ltd.; Industry
Eligibility: 18 Months to 120 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Lake Jackson, Texas

Conditions: Critical Limb Ischemia
Interventions: Ixmyelocel-T, Placebo; Biological · Other
Lead sponsor: Vericel Corporation; Industry
Eligibility: 35 Years to 90 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 86
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 63 more

Conditions: Healthy, no Evidence of Disease, Obesity, Weight Changes
Interventions: questionnaire administration, study of socioeconomic and demographic variables, survey administration, study of high risk factors; Other · Procedure
Lead sponsor: University of Southern California; Other
Eligibility: Not listed
Enrollment: 780 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Overweight and Obesity
Interventions: food-specific go/no-go computerized training, nonfood-specific go/no-go computerized training; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Duluth, Minnesota

Conditions: Hepatitis C, Chronic
Interventions: Tegobuvir (GS-9190), GS-9451, Pegasys®, Copegus®, Tegobuvir placebo, GS-9451 placebo; Drug · Biological
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 245 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 85
States / cities: Dothan, Alabama • Montgomery, Alabama • Phoenix, Arizona + 62 more

Conditions: Cancer Survivor, Central Obesity, No Evidence of Disease
Interventions: Best Practice, Exercise Intervention, Laboratory Biomarker Analysis, Monitoring Device, Quality-of-Life Assessment, Questionnaire Administration; Other · Behavioral · Device
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: No Specific Condition
Interventions: Telephone Visit; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Inguinal Hernia
Interventions: Urinary Catheter; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 491 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: No Specific Conditions Under Study. Primary Focus: Adult Subjects Who Require PICC Placement
Interventions: Sherlock 3CG, Blind Placement; Device · Other
Lead sponsor: C. R. Bard; Industry
Eligibility: 21 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Infections, Herpesviridae
Interventions: Valaciclovir, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 73 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 17
States / cities: Carmichael, California • Davis, California • Riverside, California + 13 more

Conditions: no Condition, Electroencephalography, Pupil Diameter
Interventions: Transdermal Vagus Nerve Stimulation (tVNS); Device
Lead sponsor: Arkansas Tech University; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Russellville, Arkansas

Conditions: Arrhythmias, Cardiac
Interventions: CanGaroo Envelope; Device
Lead sponsor: Elutia Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 23
States / cities: Little Rock, Arkansas • Daytona Beach, Florida • Delray Beach, Florida + 20 more

Conditions: Postoperative Wound Infection
Interventions: Wick dressing, No Wick; Procedure
Lead sponsor: Children's Healthcare of Atlanta; Other
Eligibility: 1 Day to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Hearing Loss
Interventions: Tinnitus; Procedure
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2003
U.S. locations: 1
States / cities: Portland, Oregon

Search by objective public record fields.

Can we Safely Have Our Patients Eat With Cardiac Catheterization - Nix Or alloW: The CHOW NOW Study

Effect of Calcium on Tasigna Pharmacokinetics (PK) in Healthy Volunteers

Effect of Antacids on Gleevec® in Healthy Volunteers

Pilot Study to Evaluate Safety, Tolerability, and Performance of the FAST PV Technology™ in Chronic Dialysis Patients

Randomized Control Trial of CO2 Laser to Treat Hypertrophic Burn Scar

The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit

Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation

Plant-Based, American Heart Assoc. or Mediterranean Diets In 9-18 yo With BMI >95%, Cholesterol >169 and Their Parents

Novel Non-Invasive Monitoring Parameter in Healthy Volunteers

Safety and Efficacy Study of TNX-102 SL in Subjects With Military-Related PTSD and Related Conditions

Non-invasive Monitoring: Impact on Patient Management and Outcomes

An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)

Study of a Smart Growth Community's Effect on Prevention of Obesity in Middle-, Moderately Low- and Low-Income Families

Go/No-Go Intervention for Weight Loss

A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors

Feasibility of Telephone Follow-up Visits in Primary Care

Urinary Retention After Laparoscopic Inguinal Hernia Repair: Comparing the Use of the Intraoperative Urinary Catheter

Assessment of the Precision of the Sherlock 3CG Tip Positioning System

VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

Testing the Noradrenergic Hypothesis of Transcutaneous Vagus Nerve Stimulation

CanGaroo® Registry Study

Wick vs. No Wick: Does Method of Closure Affect Rate of Wound Infection?

Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss